A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHALEON

About this trial

The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.

Eligibility criteria

Qualifiers

Participant who has provided consent indicating they have been informed of all pertinent aspects of the study.

All genders who, at the time of screening, are aged more than or equal to (>=)18 years.

Anyone who has begun to experience dentin hypersensitivity (self-reported) within the past three months.

Anyone who has started to use products to treat their tooth sensitivity within the past three months.

Disqualifiers

Anyone who has any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.

Anyone who suffers from tooth cavities, significant gum disease, cracked or fractured teeth, temporomandibular joint disease (TMD), or who has had tooth extractions or fillings within the last three months.

Anyone who wears braces (including Invisalign-like appliances) for treatment or dentures (full or partial).

Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

375 Participants
are grouped into 1 trial group

Sponsors and collaborators